Seres Therapeutics, Inc.
MCRB · NASDAQ
Bulios Fair Price
$3.77
24.8% downside
Trenutna cena
$5.01
Po podatkih Bulios Fair Price je delnica MCRB trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Seres Therapeutics, Inc. (MCRB) is a biotechnology company focused on developing microbiome-based therapies. Their research and development efforts are centered around leveraging natural bacterial communities inhabiting the human body to treat various diseases. Seres Therapeutics particularly targets areas of the gastrointestinal tract, infectious diseases, and immune disorders. The company is developing microbiome-based therapeutics aimed at restoring the health of microbial communities in patients. Their research focuses on identifying and selecting appropriate bacterial strains and their application in treating specific diseases. Shares of Seres Therapeutics, Inc. (MCRB) could be suitable for investors seeking investments in the biotechnology sector with a focus on developing innovative microbiome-based drugs.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Richard N. Kender
Employees
66
Headquarters
Cambridge
Prihajajoči dogodki
Earnings
Upcoming earnings report